Infusion Pumps Market by Product (Ambulatory Infusion Pump, Enteral Infusion Pump, Implantable Infusion Pump), Mode (Portable Infusion Pump, Stationary Infusion Pump), Operation, Application, End User - Global Forecast 2024-2030
Description
Infusion Pumps Market by Product (Ambulatory Infusion Pump, Enteral Infusion Pump, Implantable Infusion Pump), Mode (Portable Infusion Pump, Stationary Infusion Pump), Operation, Application, End User - Global Forecast 2024-2030
The Infusion Pumps Market size was estimated at USD 18.03 billion in 2023 and expected to reach USD 19.25 billion in 2024, at a CAGR 7.21% to reach USD 29.36 billion by 2030.
An infusion pump is a medical device used to deliver fluids, such as medications, nutrients, or liquids for hydration, into a patient’s body in a controlled and precise manner. These pumps are designed to administer liquids in controlled amounts over specific periods, ensuring accurate dosing and continuous delivery as required by the patient’s treatment plan. Infusion pumps are commonly used in hospitals, homecare settings, and clinics for delivering chemotherapy drugs, antibiotics, pain relievers, insulin, or other therapies requiring regulated administration. The increasing prevalence of chronic diseases and rising elderly population has established a significant need for infusion pumps for convenient delivery of medications. However, the occurrence of medication errors associated with infusion pumps, stringent regulatory requirements for product approval, and the high cost of infusion pump devices impede the development of infusion pumps. Market players are working on consistent R&D to improve the capabilities of infusion pumps while offering cost-effective products to address these limitations. Developing smart infusion pump systems with enhanced safety features and wireless connectivity presents additional opportunities for market expansion. Innovations such as integrating infusion pumps with electronic medical records (EMR), developing user-friendly interfaces, and smart alarms form opportunities for infusion pumps.
Regional Insights
The Americas region is characterized by a robust healthcare infrastructure, high government healthcare spending, and several key players, thereby driving the region's growth and demand for infusion pumps. The region is also involved in constant product innovations, and regulatory bodies such as the Food and Drug Administration (FDA) frequently streamline medical device approvals for infusion pumps. Furthermore, technological innovations have fuelled the integration of smart technologies and wireless monitoring in infusion devices. EU countries benefit from high healthcare standards and stringent regulations that ensure the quality and safety of infusion devices. Collaborations amongst member states and substantial investment in healthcare technology drive research and development for infusion pumps in the EU. The EU also experiences a rising demand for personalized medicine and home infusion therapy. The Asia-Pacific region is experiencing rapid market growth due to rising healthcare expenditures and increasing awareness of advanced therapeutic options. Countries such as China, Japan, and India contribute to the region's expansion. In China, government initiatives to modernize healthcare and expand rural access have bolstered the market growth.
Market Insights
- Market Dynamics
The market dynamics represent an ever-changing landscape of the Infusion Pumps Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.- Market Drivers
- Increasing surgical procedures and need for infusion pumps for continuous medication delivery
- Rising demand for ambulatory infusion pumps in homecare settings
- Market Restraints
- Noticeable incidences of product recall due to medical error
- Market Opportunities
- Advancements in infusion pumps with AI, ML & IoT technologies
- Improving reimbursement availability for infusion pumps
- Market Challenges
- Technical complexities and operational limitations of infusion pumps
- Market Segmentation Analysis
- Product: Advancements to improve the performance of insulin pumps to improve disease outcomes for diabetic patients
- Mode: Growing patient preference for portable infusion pumps due to innovations in homecare
- Operation: Electrically operated infusion pumps offer greater control and monitoring capabilities
- Application: Need for infusion pumps with continuous glucose level monitoring and precise dose administration for diabetes patients
- End-User: Adoption of highly-reliable and safe infusion pumps that cater to multiple disease cases in hospitals
- Market Disruption Analysis
- Porter’s Five Forces Analysis
- Value Chain & Critical Path Analysis
- Pricing Analysis
- Technology Analysis
- Patent Analysis
- Trade Analysis
- Regulatory Framework Analysis
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Infusion Pumps Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Infusion Pumps Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments- Fresenius Kabi, Mayo Clinic ink Deal On Ivenix Infusion System
Fresenius Kabi has joined forces with the esteemed Mayo Clinic to implement the innovative Ivenix Infusion System. This state-of-the-art technology promises to revolutionize the infusion pump market by offering advanced safety features and an intuitive user interface to minimize medication errors and enhance patient care. The partnership highlights a collaborative commitment to clinical excellence, with the Ivenix system as a critical component in facilitating effective, real-time infusion data integration into electronic medical records (EMRs), thus enabling healthcare professionals to deliver high-quality, efficient patient care.
Tandem Diabetes Care Launches First Automated Insulin Pump Integrated With Dexcom G7 CGM
Tandem Diabetes Care has announced the launch of an advanced automated insulin delivery system. This new offering, combined with the Dexcom G7 continuous glucose monitoring (CGM) system, embodies a landmark in precision medicine, providing diabetes patients with a more autonomous and personalized treatment solution. Leveraging cutting-edge algorithms, the system automates insulin delivery with heightened accuracy, enhancing the user's control over their glucose levels without constant manual adjustments. The union of Tandem's automated insulin pump with Dexcom's CGM system is emblematic of the strides being made in the field of diabetes care, where innovation is directly translating to improved quality of life for individuals living with this chronic illness.
Monidor Expands Remote IV Therapy Monitoring in Collaboration with B. Braun
Monidor has enhanced its market presence by partnering with B. Braun SE to advance remote IV therapy monitoring. Leveraging Monidor's expertise and B. Braun's extensive distribution network, this partnership aims to optimize infusion therapies and improve patient care. Integrating Monidor's Monidrop device and the MoniView software with B. Braun’s infusion systems facilitates accurate administration and oversight of IV fluids remotely, thus ensuring precise dosing and reducing the likelihood of manual errors.
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Infusion Pumps Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Infusion Pumps Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Abbott Laboratories, Avanos Medical, Inc., B. Braun SE, Baxter International Inc., Bayer AG, Becton, Dickinson and Company, Bio-x, Boston Scientific Corporation, Canadian Hospital Specialties Limited, Chemyx Inc., Epic Medical Pty Ltd., Fresenius Se & Co. KGaA, FUJIFILM Corporation, GE HealthCare Technologies Inc., ICU Medical, Inc., Insulet Corporation, Intera Oncology, Inc., Intuvie Holdings LLC, Ivenix, Inc., JMS Co., Ltd., Longer Precision Pump Co. Ltd. by Halma PLC, Medline Industries, LP, Medtronic PLC, Merck KGaA, Micrel Medical Devices SA, Moog Inc., Narang Medical Limited, New Era Pump Systems Inc., Nipro Corporation, Shenzhen MedRena Biotech Co., Ltd., SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD., Siemens AG, SOOIL Developments Co., Ltd., Tandem Diabetes Care, Inc., Teleflex Incorporated, Terumo Corporation, Thermo Fisher Scientific Inc., and Ypsomed AG.
Market Segmentation & Coverage
This research report categorizes the Infusion Pumps Market to forecast the revenues and analyze trends in each of the following sub-markets:- Product
- Ambulatory Infusion Pump
- Enteral Infusion Pump
- Implantable Infusion Pump
- Insulin Pump
- PCA Pump
- Syringe Pump
- Volumetric Pump
- Mode
- Portable Infusion Pump
- Stationary Infusion Pump
- Operation
- Electrically Operated
- Mechanically Operated
- Application
- Chemotherapy
- Diabetes
- Gastroenterology
- Hematology
- Pain Management
- Pediatrics
- End User
- Academic & Research Institute
- Ambulatory Care Setting
- Home Care Setting
- Hospital
- Region
- Americas
- Argentina
- Brazil
- Canada
- Mexico
- United States
- California
- Florida
- Illinois
- New York
- Ohio
- Pennsylvania
- Texas
- Asia-Pacific
- Australia
- China
- India
- Indonesia
- Japan
- Malaysia
- Philippines
- Singapore
- South Korea
- Taiwan
- Thailand
- Vietnam
- Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom
Please Note: PDF & Excel + Online Access - 1 Year
- Americas
- Market Drivers
Table of Contents
191 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Increasing surgical procedures and need for infusion pumps for continuous medication delivery
- 5.1.1.2. Rising demand for ambulatory infusion pumps in homecare settings
- 5.1.2. Restraints
- 5.1.2.1. Noticeable incidences of product recall due to medical error
- 5.1.3. Opportunities
- 5.1.3.1. Advancements in infusion pumps with AI, ML & IoT technologies
- 5.1.3.2. Improving reimbursement availability for infusion pumps
- 5.1.4. Challenges
- 5.1.4.1. Technical complexities and operational limitations of infusion pumps
- 5.2. Market Segmentation Analysis
- 5.2.1. Product: Advancements to improve the performance of insulin pumps to improve disease outcomes for diabetic patients
- 5.2.2. Mode: Growing patient preference for portable infusion pumps due to innovations in homecare
- 5.2.3. Operation: Electrically operated infusion pumps offer greater control and monitoring capabilities
- 5.2.4. Application: Need for infusion pumps with continuous glucose level monitoring and precise dose administration for diabetes patients
- 5.2.5. End-User: Adoption of highly-reliable and safe infusion pumps that cater to multiple disease cases in hospitals
- 5.3. Market Trend Analysis
- 5.3.1. Established healthcare infrastructure and supportive regulatory landscape in the Americas region
- 5.3.2. Rising prevalence of chronic diseases and significant investments in healthcare infrastructures enhancing deployment of infusion pumps in the Asia-Pacific
- 5.3.3. Widespread presence of market vendors focusing on advancements in infusion pumps across EMEA region
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter’s Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework Analysis
- 6. Infusion Pumps Market, by Product
- 6.1. Introduction
- 6.2. Ambulatory Infusion Pump
- 6.3. Enteral Infusion Pump
- 6.4. Implantable Infusion Pump
- 6.5. Insulin Pump
- 6.6. PCA Pump
- 6.7. Syringe Pump
- 6.8. Volumetric Pump
- 7. Infusion Pumps Market, by Mode
- 7.1. Introduction
- 7.2. Portable Infusion Pump
- 7.3. Stationary Infusion Pump
- 8. Infusion Pumps Market, by Operation
- 8.1. Introduction
- 8.2. Electrically Operated
- 8.3. Mechanically Operated
- 9. Infusion Pumps Market, by Application
- 9.1. Introduction
- 9.2. Chemotherapy
- 9.3. Diabetes
- 9.4. Gastroenterology
- 9.5. Hematology
- 9.6. Pain Management
- 9.7. Pediatrics
- 10. Infusion Pumps Market, by End User
- 10.1. Introduction
- 10.2. Academic & Research Institute
- 10.3. Ambulatory Care Setting
- 10.4. Home Care Setting
- 10.5. Hospital
- 11. Americas Infusion Pumps Market
- 11.1. Introduction
- 11.2. Argentina
- 11.3. Brazil
- 11.4. Canada
- 11.5. Mexico
- 11.6. United States
- 12. Asia-Pacific Infusion Pumps Market
- 12.1. Introduction
- 12.2. Australia
- 12.3. China
- 12.4. India
- 12.5. Indonesia
- 12.6. Japan
- 12.7. Malaysia
- 12.8. Philippines
- 12.9. Singapore
- 12.10. South Korea
- 12.11. Taiwan
- 12.12. Thailand
- 12.13. Vietnam
- 13. Europe, Middle East & Africa Infusion Pumps Market
- 13.1. Introduction
- 13.2. Denmark
- 13.3. Egypt
- 13.4. Finland
- 13.5. France
- 13.6. Germany
- 13.7. Israel
- 13.8. Italy
- 13.9. Netherlands
- 13.10. Nigeria
- 13.11. Norway
- 13.12. Poland
- 13.13. Qatar
- 13.14. Russia
- 13.15. Saudi Arabia
- 13.16. South Africa
- 13.17. Spain
- 13.18. Sweden
- 13.19. Switzerland
- 13.20. Turkey
- 13.21. United Arab Emirates
- 13.22. United Kingdom
- 14. Competitive Landscape
- 14.1. Market Share Analysis, 2023
- 14.2. FPNV Positioning Matrix, 2023
- 14.3. Competitive Scenario Analysis
- 14.3.1. Fresenius Kabi, Mayo Clinic ink Deal On Ivenix Infusion System
- 14.3.2. Tandem Diabetes Care Launches First Automated Insulin Pump Integrated With Dexcom G7 CGM
- 14.3.3. Monidor Expands Remote IV Therapy Monitoring in Collaboration with B. Braun
- 14.3.4. FDA Clears New Infusion Pump And Software From ICU Medical
- 14.3.5. B. Braun Launches DoseTrac Enterprise Infusion Management Software
- 14.3.6. Medtronic Agrees To Buy Korean Insulin Patch Pump Maker For USD 738 Million To Boost Diabetes Business
- 14.3.7. Eitan Medical Launches Connected Avoset Infusion Platform
- 14.3.8. FDA Approves Medtronic MiniMed 780G System World's First Insulin Pump with Meal Detection Technology Featuring 5-Minute Auto Corrections
- 14.3.9. MLH Enhances Medication Safety with Epic-Integrated IV Pumps
- 14.3.10. Insulet Acquires Insulin Pump Patents from Bigfoot Biomedical as Both Companies Prioritize Improved Insulin Delivery Technologies
- 14.3.11. Mindray Launches BeneFusion i/u Series Infusion Systems, Providing Visible Safety for All with Ease
- 14.3.12. Tandem Diabetes Care Completes Acquisition of Insulin Pump Maker AMF Medical
- 15. Competitive Portfolio
- 15.1. Key Company Profiles
- 15.2. Key Product Portfolio
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
